QIAGEN N.V. Equity Method Investment, Other than Temporary Impairment
QIAGEN N.V. (QGEN) reported Equity Method Investment, Other than Temporary Impairment of $2.50 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-03-20
| Period end | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|
| 2025-12-31 | $2.50M 20-F · filed 2026-03-20 |
| 2024-12-31 | $2.40M 20-F · filed 2026-03-20 |